Brilaroxazine

RP5063 · Reviva Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Brilaroxazine, covering 2024-12-19 to 2024-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia [Phase 3]